by Bühler UK Ltd
Oct 28th, 2021
2 mins
BFFF

Christoph Goppelsroeder (62) was unanimously elected to Bühler’s Board of Directors at an extraordinary general shareholders’ meeting today. With his appointment, the Board of Directors is gaining an experienced executive who has played a crucial role in innovation and who puts customer needs first.

Swiss national Christoph Goppelsroeder began his career at The Boston Consulting Group. From 1994 to 2003, he held management positions at Roche Vitamins in Switzerland, Belgium, and the US. He joined DSM through their acquisition of Roche’s Vitamins business in 2003 when he co-led the integration of Roche Vitamins and acted as DSM Managing Board member from 2005 to 2006. From 2007 to 2012, he oversaw Syngenta’s Global Seed Care Division. In 2013, Christoph Goppelsroeder was appointed President and CEO of DSM Nutritional Products, DSM’s largest business, and Member of DSM’s Executive Committee. He led the division on a robust growth path, both organically as well as through acquisitions. He retired on April 1, 2021.

Christoph Goppelsroeder studied Civil Engineering at ETH in Zurich and holds an MBA from Insead, Fontainebleau.

Webinars

Nov 1st, 2021
3 mins

Lumina Intelligence give cautious optimism with menu counts increasing season-on-season in the latest BFFF industry webinar

Oct 28th, 2021
1 min

Butterflies in a Hurricane: Navigating Turbulence in Wholesale Energy Markets - BFFF exclusive

Sep 22nd, 2021
1 min

TRANSPORT AND GROUPAGE BREXIT SUPPORT SESSION

Sep 16th, 2021
1 min

FROZEN OPPORTUNITIES PRESENTED BY HFSS RECORDING

Aug 19th, 2021
1 min

The Future of Imports Recording

Jul 22nd, 2021
1 min

Integrating Social Value into your business recording

May 20th, 2021
1 min

KANTAR - THAWING OF LOCKDOWN RESTRICTIONS